While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...

Cipla share price will remain in focus after the United States Food and Drug Administration (USFDA) has classified the ...

The USFDA has conducted routine cGMP inspection at the facility in the period between November 7 through November 13, 2024.

Join us on the Cipla Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in ...

>> Long build up is seen in CIPLA Futures, where we have seen 4 per cent rise in the open interest on the day when Cipla ...

Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock. Keep track of Cipla with the latest details, including: Last traded price ...

The Indian Pharmaceuticals Market continued to deliver healthy growth at 8.7% year-on-year in January 2025, against 7.7% year ...

Despite conflicting international signals, the early Gift Nifty movement on Monday, February 10th, suggested a promising ...

Stocks including LIC, Bharat Electronics, Vedanta, Glenmark Pharma, Cipla, FirstCry, NHPC, VA Tech Wabag and more will be in ...

Indian pharma stocks experienced heavy selling on February 10, influenced by weak earnings and concerns over possible U.S.

Catch up on the latest stock market updates!

Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the Company’s manufacturing facility in Virgonagar, Bengaluru, India ...